Arcadia Biosciences
RKDA
28 hedge funds and large institutions have $19.4M invested in Arcadia Biosciences in 2015 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 4 closing their positions.
100% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 4
17% more funds holding
Funds holding: 24 → 28 (+4)
0% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 5
51% less capital invested
Capital invested by funds: $39.6M → $19.4M (-$20.2M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
+$429K |
| 2 |
Northern Trust
Chicago,
Illinois
|
+$362K |
| 3 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$258K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$191K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$112K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$387K |
| 2 |
WAM
Weiss Asset Management
Boston,
Massachusetts
|
-$318K |
| 3 |
SIM
Spark Investment Management
New York
|
-$167K |
| 4 |
Wells Fargo
San Francisco,
California
|
-$108K |
| 5 |
SG Americas Securities
New York
|
-$25K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
BNP Paribas Financial Markets
Paris,
France
| $5.79K | +$8.32K | +2 | New |
|
27
Royal Bank of Canada
Toronto,
Ontario, Canada
| $3K | – | – | – |
|
28
Morgan Stanley
New York
| $3K | +$4.16K | +1 | New |
|
|
WAM
29
Weiss Asset Management
Boston,
Massachusetts
| – | -$318K | -63 | Closed |
|
|
SIM
30
Spark Investment Management
New York
| – | -$167K | -33 | Closed |
|
|
31
Wells Fargo
San Francisco,
California
| – | -$108K | -26 | Closed |
|
|
SO
32
STRS Ohio
Columbus,
Ohio
| – | -$12.5K | -3 | Closed |
|
RKDA Hedge Fund Activity: Q3 2015 in Review
28 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Arcadia Biosciences (RKDA) for Q3 2015, worth a combined $19.4M — down 51% from $39.6M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new RKDA positions and 4 closed out — a net gain of 4 holders — while 5 added to existing stakes and 5 trimmed.
The largest buyer was Goldman Sachs, opening a new position worth an estimated $429K. The largest seller was UBS O'Connor, cutting an estimated $387K.
- 28 institutional investors held Arcadia Biosciences (RKDA) as of Q3 2015, up from 24 in Q2 2015.
- Funds reported $19.4M of Arcadia Biosciences stock for Q3 2015, down 51% quarter-over-quarter.
- 8 funds opened new Arcadia Biosciences positions in Q3 2015 and 4 closed out, a net change of +4 holders.
- The largest Arcadia Biosciences buyer in Q3 2015 was Goldman Sachs, an estimated $429K added.
- The largest Arcadia Biosciences seller in Q3 2015 was UBS O'Connor, an estimated $387K sold.
Based on aggregated 13F filings for Q3 2015.